Expanding global access to cancer therapies focuses on making life-saving treatments affordable and available to patients worldwide. The growth of generics, biosimilars, and cost-effective manufacturing is helping reduce treatment costs in low- and middle-income countries. International collaborations and global health programs are improving distribution, screening, and early diagnosis. Efforts to strengthen healthcare infrastructure and simplify regulatory pathways are further enhancing access. Overall, this movement aims to ensure that advanced cancer treatments reach every patient, regardless of geography or economic status.